A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.

Autor: Zhang, JY, Dai, M, Wang, X, Lu, WQ, Li, DS, Zhang, MX, Wang, KJ, Dai, LP, Han, SG, Zhou, YF, Zhuang, H, Zhang, J Y, Lu, W Q, Li, D S, Zhang, M X, Wang, K J, Dai, L P, Han, S G, Zhou, Y F

Publikováno v: International Journal of Epidemiology; Aug1998, Vol. 27 Issue 4, p574-578, 5p

Cervical Spondylotic Myelopathy Treated by Anterior Multilevel Decompression and Fusion

Autor: Ye Lx, Yang Kc, Lu Wq, Lu Xs, Cai Ql

Publikováno v: Clinical Orthopaedics and Related Research. 221:161

From 1974 to 1982, 214 patients were treated for cervical spondylotic myelopathy by anterior multilevel decompression and the Robinson anterior interbody fusion and followed for an average of three years and 11 months. Postoperative results were supe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9aac99a602bfbcf3afcaff1050a369f1
https://doi.org/10.1097/00003086-198708000-00018

Modeling The Cost-Effectiveness of Ilaprazole Vs. Omeprazole for The Treatment of Newly Diagnosed Duodenal Ulcer Patients In China.

Autor: Lu, YJ¹, Xu, GX², Lu, WQ², Liu, Z², Rl, Song³, Xuan, J⁴, Lu, Y J¹ (AUTHOR), Xu, G X² (AUTHOR), Lu, W Q² (AUTHOR)

Publikováno v: Value in Health. Nov2015, Vol. 18 Issue 7, pA625-A625. 1p.

LOXL1 promotes gastric cancer progression by β-catenin-cyclinD mediated proliferation.

Autor: Liang JE; Department of Medical Oncology, the First Hospital of China Medical University, Shenyang, 110001, China; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, the First Hospital of China Medical University, Shenyang, 110001, China; Clinical Cancer Research Center of Shenyang, the First Hospital of China Medical University, Shenyang, 110001, China; Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, 441000, China., Bao BW; Department of Medical Oncology, the First Hospital of China Medical University, Shenyang, 110001, China; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, the First Hospital of China Medical University, Shenyang, 110001, China; Clinical Cancer Research Center of Shenyang, the First Hospital of China Medical University, Shenyang, 110001, China., He XH; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, the First Hospital of China Medical University, Shenyang, 110001, China; Clinical Cancer Research Center of Shenyang, the First Hospital of China Medical University, Shenyang, 110001, China; Department of Respiratory and Infectious Disease of Geriatrics, The First Hospital of China Medical University, Shenyang, Liaoning, China., Lu WQ; Department of Medical Oncology, the First Hospital of China Medical University, Shenyang, 110001, China; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, the First Hospital of China Medical University, Shenyang, 110001, China; Clinical Cancer Research Center of Shenyang, the First Hospital of China Medical University, Shenyang, 110001, China., Liu Y; Department of Medical Oncology, the First Hospital of China Medical University, Shenyang, 110001, China., Wang J; Department of Medical Oncology, the First Hospital of China Medical University, Shenyang, 110001, China; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, the First Hospital of China Medical University, Shenyang, 110001, China; Clinical Cancer Research Center of Shenyang, the First Hospital of China Medical University, Shenyang, 110001, China., Qu XJ; Department of Medical Oncology, the First Hospital of China Medical University, Shenyang, 110001, China; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, the First Hospital of China Medical University, Shenyang, 110001, China; Clinical Cancer Research Center of Shenyang, the First Hospital of China Medical University, Shenyang, 110001, China., Li DY; Department of Medical Oncology, the First Hospital of China Medical University, Shenyang, 110001, China; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, the First Hospital of China Medical University, Shenyang, 110001, China; Clinical Cancer Research Center of Shenyang, the First Hospital of China Medical University, Shenyang, 110001, China. Electronic address: lisa50725072@163.com., Che XF; Department of Medical Oncology, the First Hospital of China Medical University, Shenyang, 110001, China; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, the First Hospital of China Medical University, Shenyang, 110001, China; Clinical Cancer Research Center of Shenyang, the First Hospital of China Medical University, Shenyang, 110001, China. Electronic address: xfche@cmu.edu.cn.

Publikováno v: Experimental cell research [Exp Cell Res] 2024 Nov 13; Vol. 443 (2), pp. 114331. Date of Electronic Publication: 2024 Nov 13.

How flow and mindfulness interact with each other in mindfulness-based augmented reality mandala coloring activities.

Autor: Chen H; School of Film Television & Communication, Xiamen University of Technology, Xiamen, China.; Business Analytics Research Center, Chang Gung University, Taoyuan, Taiwan., Liu C; Business Analytics Research Center, Chang Gung University, Taoyuan, Taiwan.; School of Journalism and Communication, Huaqiao University, Xiamen, China., Zhang A; Teachers College, Beijing Union University, Beijing, China., Lu WQ; College of Mechanical Engineering and Automation, Huaqiao University, Xiamen, China., Wu K; Business Analytics Research Center, Chang Gung University, Taoyuan, Taiwan., Chiou WK; Department of Industrial Engineering and Management, Ming Chi University of Technology, New Taipei, Taiwan.; Department of Psychiatry, Chang Gung Memorial Hospital, Taoyuan, Taiwan.; Department of Industrial Design, Chang Gung University, Taoyuan, Taiwan.

Publikováno v: Frontiers in psychology [Front Psychol] 2024 Jan 08; Vol. 14, pp. 1301531. Date of Electronic Publication: 2024 Jan 08 (Print Publication: 2023).